Citing financial pressure from the loss of its patent on Zyprexa, Eli Lilly announced that it will freeze base pay for most of its employees in 2012.
Read more Discuss →
Citing financial pressure from the loss of its patent on Zyprexa, Eli Lilly announced that it will freeze base pay for most of its employees in 2012.
Read more Discuss →
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
***
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.